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viruses to make the best of apoptosis
A Richard*
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1
Viral infection constitutes an unwanted intrusion that needs to be eradicated by host cells. On one hand, one of the ﬁrst protective
barriers set up to prevent viral replication, spread or persistence involves the induction of apoptotic cell death that aims to limit the
availability of the cellular components for viral ampliﬁcation. On the other hand, while they completely depend on the host molecular
machinery, viruses also need to evade the cellular responses that are meant to destroy them. The existence of numerous antiapoptotic
products within the viral kingdom proves that apoptosis constitutes a major threat that should better be bypassed. Among the different
strategiesdevelopedtodealwithapoptosis,oneisbasedonwhatvirusesdobest:backﬁringthecellonitself.Severalunrelatedviruses
have been described to take advantage of apoptosis induction by expressing proteins targeted by caspases, the key effectors of
apoptotic cell death. Caspase cleavage of these proteins results in various consequences, from logical apoptosis inhibition to more
surprising enhancement or attenuation of viral replication. The present review aims at discussing the characterization and relevance
of this post-translational modiﬁcation that adds a new complexity in the already intricate host–apoptosis–virus triangle.
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Apoptosis Faces Up Viruses: Die Hard
When a viral infection threatens cells, one of the ﬁrst
measures they take is to induce apoptosis to restrict viral
replication and spread.
1–3 Dying this way, host cells are likely
to generate speciﬁc signals aiming at triggering the immune
system with innate and/or adaptative responses allowing the
eradication of the invader.
4,5 On the other hand, viruses have
evolved a huge arsenal of strategies meant to either counter-
act or deal with this destructive process to ensure their
survival.
6–8 Apoptotic cell death is accompanied by charac-
teristic morphological changes (cellular rounding-up and
volume reduction, chromatin condensation, nuclear fragmen-
tation, plasma membrane blebbingy) and at a molecular
level by the activation of ﬁrst initiator and then effector
cysteinyl aspartate proteinases or caspases.
9,10 Activated
caspases act through a catalytic Cys that hydrolyzes peptide
bonds within the substrate, with a stringent speciﬁcity for Asp
residue at P1 position (the nature of residues at positions P2,
P3 and P4 depending on the caspase). Caspase substrates
include a large number and variety of cellular proteins that
participate through their cleavage to the strong apoptosis-
related morphological changes, as well as other physiological
processes. Interestingly, viral proteins are also likely to be
cleaved by caspases but until 2004, only four of them were
reported as such and suggested as advantaging the
associated viruses through their cleavage.
11 Since, their
number has greatly increased and at least 16 viruses are now
known to express proteins that undergo caspase cleavage.
Here, we aim at updating these cleavages and discussing
their biological relevance. From apoptosis inhibition to the
improvement or attenuation of viral ampliﬁcation, caspase
cleavage of VPs highlights a potential new fascinating viral
strategy to handle apoptosis induction.
Caspase Cleavage as a Way for Viruses to Counteract
Apoptosis: Die Another Day
Apoptosis induction by infected cells is meant to jeopardize
viral replication. Therefore, many viruses have developed
strategies to inhibit this process throughvarious mechanisms.
Among them, inhibiting caspase activity through the cleavage
of viral proteins constitutes an effective way to achieve
apoptosis suppression (Table 1).
Baculoviruses are invertebrate viruses that encode several
antiapoptotic products including IAPs, P49 and P35. When
lacking P35, the baculovirus prototype Autographa californica
multicapsid nucleopolyhedrovirus (AcMNPV) induces apop-
tosis and fails to replicate, whereas P35 rescue inhibits cell
death and restores viral replication.
12 Interestingly, P35 is
proteolytically cleaved on infection
13,14 and the
84DQMD
87k
cleavage site is required for P35-mediated apoptosis
suppression. P35 directly inhibits many caspases, including
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mousecaspase1.
14,15Indeed,P35cleavageproductsremain
irreversibly associated to the caspase through a covalent
thioester bond between P35 D87 residue and the caspase
catalytic cysteine.
16,17 Although being 50%-related to P35,
P49 yet exhibits a different caspase cleavage site
(
91TVTD
94k)thatconferstoP49itsantiapoptoticproperties.
18
Caspase suppression by P49 also involves its cleavage by
and stable association to the targeted caspases although
acting as a dimer.
19 Besides effector caspases, P49 also
affects initiator caspases that P35 fails to suppress, like insect
Sf-caspase X and human initiator caspase 9.
Rather similarly, the product of the orf390 gene expressed
by the crustacean-infecting white spot syndrome virus
(WSSV) was also shown to exert antiapoptotic properties.
Insect cells SF9 stably expressing orf390 gene strongly resist
both viral- and actinomycin D-induced apoptosis.
20 Like P35
and P49, ORF390 (also referred as WSSV449 or AAP-1) is
suggested to act as an inhibitor substrate
21 and is able to
blockseveralcaspases,includinghumancaspases3and9as
well as insect Sf-caspase 1 in vitro. ORF390 ability to
suppress caspase activity is associated with consensual
caspasecleavage sites:
269DEVD
272k that targets caspase3,
and
230VETD
233k and
300LEHD
303k that are both required for
caspase 9 inhibition. Although each site speciﬁcally targets
one protease, the three of them are needed to reach maximal
caspase inactivation.
20
For baculoviruses and WSSV, inhibiting apoptosis is crucial
to achieve their life cycle. These different invertebrate-
infecting viruses encode proteins exhibiting active caspase
cleavage sites, just as cellular substrates do, but with the
special ability to irreversibly freeze the protease activity. This
leads to a very potent and broad caspase inhibition, which
keeps the host cell machinery available and ﬁt for viral
ampliﬁcation.
Caspase Cleavage as a Way for Viruses to Replicate and
Spread: Live and Let Die
Unlike the expression of antiapoptotic products, the require-
ment of apoptosis for viruses to survive is a way more
counterintuitive strategy that yet has been evolved by several
viruses and involves caspase cleavage (Table 2).
Parvovirus Aleutianminkdisease virus(AMDV) canlead,at
a single cell level, to either permissive infection, namely high
levels of both viral DNA replication and production of viruses,
or persistent infection with low viral DNA replication and
almost no production of progeny virions. On permissive
infection, AMDV induces caspase activation that is necessary
for viral ampliﬁcation.
22 This requirement was associated with
NS1 protein being cleaved through two caspase 3 sites
leading to ﬁve NS1-related products.
23 When one site is
mutatedwithin AMDV molecularclones, theviral productionis
strongly reduced and even aborted when both sites are
disrupted. Interestingly, wild-type (WT) NS1 protein, which
exerts replicative and transcriptional functions, is mostly
nuclear, but when one of its cleavage sites is disrupted, the
protein remains cytosolic resulting in a dramatic decrease in
NS1-dependent viral protein (VP) expression. NS1-related
C-terminal products, also nuclear, are suggested to be actively
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2
Cell Death and Diseaseinvolved in the transport of WT NS1. Therefore, on apoptosis
induction, full replication occurs, leading to permissive infection.
Conversely, without caspase activation, AMDV ampliﬁcation
would be limited and that might allow this lytic virus to
establish persistent infection.
Human papillomavirus (HPV) is mostly known to infect
epithelial cells of the genital tract and cause cervical cancers.
On epithelial differentiation, HPV induces a DNA damage
response that leads to caspase 3-dependent apoptosis.
24
Interestingly, HPV E1, a protein involved in viral DNA
replication, is a target for caspases 3 and 7 at a site that is
conserved in all genital HPVs and preventing E1 cleavage
reduces viral ampliﬁcation. When compared with chemically
induced apoptosis, HPV-induced apoptotic markers are
limited. Interestingly, HPV increases the levels of both
antiapoptotic Bcl2 and Survivin proteins.
25 HPV pro- and
antiapoptotic properties might achieve a caspase activity
threshold that is sufﬁcient for E1 cleavage and viral
ampliﬁcation, but not lethal for the host cell. Besides E1,
HPV E6 protein is cleaved by caspases as well, but the
functional consequences remain unknown.
26
Human astroviruses (HAstV) are responsible for gastro-
enteritis. In Yuc8 strain, orf2 encodes the precursor of viral
capsid proteins, VP90, whose processing yields VP70.
Besides, HAstV activates caspases 3, 4, 6, 7, 8 and 9.
27,28
In vitro, caspases 3, 8 and 9 are able to target VP90
27 but only
caspase 3 or 9 silencing reduces VP70 generation on
infection. Interestingly, both intracellular VP90 processing
into VP70 and progeny virion release are lost in the presence
ofapancaspaseinhibitor.However,inoppositiontowhatwas
ﬁrst suggested, viral release needs caspase activation but
does not need VP90 processing into VP70 to be achieved.
27
But yielding fully infectious viruses does require shorter
polypeptides to be created through VP70 further processing
by trypsin. Thus, ﬁrst cleaving VP90 to generate VP70
likely represents a crucial intermediate event during HAstV
infection.
SARS-coronavirus (SARS-CoV) is a fairly new RNA virus
responsible for a severe acute respiratory disease. SARS-
CoV leads to either permissive or persistent infection, with
strong cytopathic effects and high viral titers or the opposite,
respectively. Interestingly, the nucleocapsid protein (N), that
has both structural and non-structural functions, is proteo-
lytically processed in cells undergoing a lytic cycle or
ectopically expressing the protein.
29 Using a pharmalogical
approach, N protein was demonstrated to be targeted by
caspases3and6.Onpermissiveinfection,Nproteinlocalizes
in both cytosol and nucleus while remaining cytosolic in cells
undergoing persistent infection. Moreover, preventing N from
translocating to the nucleus by mutating its nuclear localiza-
tion signal abolishes its cleavage by caspases. Thus,
permissive infection is associated with N being translocated
to the nucleus and possibly its ensuing caspase cleavage.
Nevertheless, the mechanisms underlying viral replication,
N subcellular localization and N caspase processing are
unknown so far.
In sharp contrast with baculoviruses and WSSV, several
verydifferentvirusesevolvedtohijackapoptosiswithcaspase
cleavage being required to reach optimal viral ampliﬁcation.
Based on the well-described case of AMDV, we can
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3
Cell Death and Diseasehypothesize that the caspase-related products created
through cleavages display novel properties required for the
achievement of the viral life cycle.
Caspase Cleavage as a Way for Viruses to Downregulate
Their Own Expression: You Only Live Twice
In some cases, apoptosis induction by the host cell leads
to exactly what is expected, namely viral attenuation,
but surprisingly with the help of viral protein cleavages.
The possible viral advantage resulting from such an event
is discussed (Table 3).
Kaposi sarcoma-associated herpesvirus (KSHV) estab-
lishes long-term infections leading to Kaposi sarcomas and
can go through either latent or lytic cycle. When KSHV is
reactivated, ORF57 (or Mta or KS-SM) is detected by western
blot as a doublet,
30 with the smaller product being abolished
by a pan caspase inhibitor. In vitro, caspase 7, which is
activated on KSHV reactivation, and to a lesser extent
caspases5and10,areabletoprocessORF57at
30DETD
33k.
Interestingly, coexpression assays show that ORF57 clea-
vage product (i.e. ORF57 lacking residues 1–33) is no longer
able to promote viral lytic gene expression. Accordingly,
complementing a stable cell line containing an orf57-null
KSHV genome with ectopic WT or uncleavable ORF57
promotes lytic gene expression, while ORF57 lacking
residues 1–33 does not. Consistently, the number of cell-free
virus particles dramatically increases when caspase 7 is
inhibited. Thus, ORF57 cleavage would prevent proper
expression of its downstream targets and subsequent full
reactivation of KSHV, suggesting that it allows KSHV to
maintain a persistent infection.
As described above, AMDV NS1 protein is cleaved by
caspases, which allows full viral replication. Interestingly,
AMDV capsid proteins VP1 and 2 are also processed by
caspases on viral infection or ectopic expression.
31 The
cleavage generates a stable 26-kDa product, VPx, and can
be partly prevented by the pharmacological inhibition of
caspases 6, 8, 9 and 10, and completely by a pan caspase
inhibitor. Besides, VP protein expression in either transfected
or AMDV-infected cells mainly activates caspase 10, followed
bycaspases6,9,3and7,withcaspase7asthemoreefﬁcient
in VP cleavage in vitro. Altogether, these data argue for the
involvement of several caspases in VP cleavage. AMDV-G
strain grows more efﬁciently at 31.81C than 371C. The
alteration of the caspase site within AMDV-G increases both
VP and genomic copies production at the non-optimal
temperature of 371C and shows no signiﬁcant effects at
31.81C, suggesting that VP caspase cleavage attenuates
AMDV-G life cycle. In vivo AMDV-G infection might thus be
regulated by active caspases because it only occurs at 371C.
Interestingly, NS1 cleavage favors viral DNA replication while
VP processing would limit the packaging of progeny virions.
As it is possible that both NS1 and VP cleavages do not
inevitably occur simultaneously depending on the pattern of
activated caspases, it would result in either effective
or attenuated viral replication and allow the virus to spread
or persist.
H-1 parvovirus (H-1PV) displays oncotropic and oncolytic
features meaning it preferentially replicates in and kills
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H-1PV is able to activate caspases in non-transformed cells,
leading to the cleavage of NS1, a non-structural protein (NS)
notably involved in viral DNA replication and gene expression
by transactivating P38 promoter, which controls the synthesis
of capsid proteins. Cleaved NS1 protein (named NS1-Nterm)
lacks its C-terminal transactivation domain. When ectopically
expressed, NS1-Nterm acts as a dominant negative on
NS1-driven P38 promoter transactivation, and dramatically
decreases viral production. Moreover, a molecular clone
expressing an uncleavable version of NS1 tends to generate
more virions. As cancer cells are often refractory to proper
apoptotic induction, we propose that H-1PV oncotropism is
due, at least in part, to the inability of cancer cells to cleave
NS1 protein, thus allowing strong virus production. On the
other hand, NS1 cleavage would act as a sensor of antiviral
defenses and accordingly attenuate viral ampliﬁcation, likely
to favor persistent infection (our unpublished results).
Crimean-Congo hemorrhagic fever virus (CCHFV) causes
severe coagulation dysfunction in humans. CCHFV nucleo-
capsid protein (NP) is an important structural protein also
involved in viral replication and, when ectopically expressed
with an apoptotic factor such as Bax protein, it generates two
fragments through cleavage at a consensual
266DEVD
269k
motif.
32 A caspase 3 inhibitor and cells lacking caspase 3 both
allows a one log-increase in the production of virions, which
suggests that caspase activation is involved in CCHFV
attenuation. Thus, NP caspase cleavage and/or NP-related
products may participate to this attenuation although the
mechanisms remain to be investigated. Interestingly, the
caspase cleavage site is conserved within all the strains that
were checked, suggesting that it is an important feature for
CCHFV regulation.
Caspase cleavages of viral proteins can result in the atten-
uation of the virus. Rather than a weakness of the virus, this
might be considered as a way for the virus to adapt to the
cellular context: as a result of such viral attenuation, the host
response is largely reduced while the virus keeps its ability to
replicate to some extent.
Unknown Functions of viral protein Caspase Cleavages:
On her Majesty’s Secret Service
Although the consequences of several caspase protein
cleavages have been elucidated, they remain elusive so far
for others (Table 4).
Inﬂuenza viruses are structured into ribonucleoprotein
segments consisting of viral RNA and viral proteins, the major
one being the NP. Unlike avian NP, NP proteins from human
inﬂuenza A and B viruses are long known to be caspase
targets.
33,34 Human inﬂuenza with uncleavable (‘avian-like’)
NP is dramatically less lethal for mice, along with lower viral
titers and faster clearance than its WT counterpart. This
argues for the involvement of NP caspase cleavage in the
virulence of inﬂuenza virus. But making avian NP cleavable
(i.e. making the protein ‘human-like’ by introducing the same
caspase cleavage site) does not enhance the viral virulence
as could have been expected. Thus, modulating inﬂuenza
pathogenicity through NP caspase cleavage would be a
speciﬁcity of human strains that cannot be extrapolated to
avian ones.
35 However, avian inﬂuenza pathogenicity might
still be regulated by caspase cleavage. The viral ionic channel
M2 protein is also cleaved by caspases, likely caspase 2 and/
or 3
36,37 in both human and avian inﬂuenza viruses and was
shown to be associated with avian inﬂuenza pathogenicity.
37
Altogether, these studies highlight that modulating inﬂuenza
caspase sites attenuates the virus although through currently
unknown mechanisms.
37,38
Hepatitis C virus (HCV) often leads to chronic infection
evolving to cirrhosis and possibly hepatocellular carcinoma.
HCV core protein induces activation of caspases 2 and 6, and
interacts with viral NS5A protein that is cleaved by the
activated caspases.
39–42 Several studies point to a role of
NS5A cleavage in its subcellular localization. The protein is
mainly found in the cytosol while exerting nuclear functions.
NS5A caspase cleavage was ﬁrst suggested to allow the
removal of a C-terminal cytoplasmic retention signal along
with the translocation of the C-terminal deleted NS5A to the
nucleus, reminding what was already described for AMDV
NS1 protein.
42 However, a study more recently reported a
cytosolic localization of these C-terminal truncated forms of
NS5A and no obvious role of NS5A caspase cleavage in its
trafﬁcking.
40 Although its characterization is well admitted, the
functional relevance of NS5A cleavage is still debated.
Transmissible gastroenteritis coronavirus (TGEV) causes
acute and fatal diarrhea in newborn piglets. TGEV infection is
able to induce caspases 3, 6, 7, 8 and 9 activation
43,44 and the
cleavage of the structural NP N, leading to a stable 41-kDa
fragment (N0).
44 N protein is targeted in vitro by caspases 6
and 7, and less efﬁciently by caspase 3. In HRT18jap1 cells,
the infection causes apoptosis but is not productive, suggest-
ingthatcaspaseactivation(andpossiblyNcaspasecleavage)
prevents progeny virion generation. However, caspase
inhibition in this context does not restore any viral production.
Owing to the lack of satisfactory tools, human HRT18jap1
cells were used as a study model but might not be appropriate
to reveal N caspase cleavage relevance, notably for virus
production. Further digging will thus be needed to understand
the biological signiﬁcance of N processing by caspases on
TGEV infection.
Feline calicivirus (FCV) causes upper respiratory tract
disease in cats. FCV capsid protein is synthesized as a
precursor further cleaved by the viral protease. However, a
40-kDa product (P40) is also usually observed at late stages
of FCVinfection and canbeabolishedwith a pancaspaseor a
caspase 3/7 inhibitor.
45 Accordingly, FCV-infected cells
undergoapoptosisaswellascaspases2,3and7activation.
46
Onlycaspase2andfarlessefﬁcientlycaspase6processFCV
capsid protein in vitro at cleavage sites that have not been
described yet. As suggested for instance for AMDV, cleavage
of the capsid protein might impair particle assembly and
participate to viral persistence but this has not been
investigated either.
Adenovirusesgathermorethana100specieswithabout40
being able to infect humans. Adenovirus early region 1A
(AdE1A) encodes two major proteins, 12S and 13S, that are
involved in the control of early viral gene expression through
their interactions with the host cell machinery. In vitro,
caspases 3 and 7 are able to cleave both 12S and 13S
proteins, although the cleavage efﬁciency depends on the
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Cell Death and Diseaseviral serotype. Furthermore, when apoptosis is chemically
induced in AdE1A-transformed cells, AdE1A levels decrease
but can berestored usinga pan caspase inhibitor.
47 However,
AdE1A levels remain stable on adenovirus infection despite
TNFa-induced caspase activation. Thus, although AdE1A
caspase cleavage is likely to occur, its existence on infection
as well as its biological relevance for adenoviruses remains
elusive so far. Interestingly, AdE1A-binding abilities to
transcription factors such as CBP and TBP are affected by
the cleavage, suggesting that it might modulate the expres-
sion of early viral genes.
Molluscum contagiosum virus (MCV) is a poxvirus that, like
variola, exclusively infects humans. MC159P, an MCV
protein, exhibits antiapoptotic properties by protecting cells
from Fas-induced apoptosis through caspase 8 inhibition but
is not targeted by caspases.
48 On the other hand, MC160P is
not associated with any antiapoptotic abilities but in vitro,i s
cleaved by caspases 3 and 8.
48 When expressed through
vaccinia virus, MC160P is also speciﬁcally cleaved by
caspases on Fas-induced apoptosis while MC159P remains
stable, as expected. MC159P and MC160P being thought to
be produced simultaneously, a balance might take place
between MC159P antiapoptotic response and MC160P
caspase cleavage. However, the pathophysiological signiﬁ-
canceofthisbalanceisdifﬁculttoaddressbecauseMCVdoes
not grow in tissue culture or experimental animals.
Herpex simplex virus 1 (HSV-1) causes lifelong infections
affectingbetween50and90%oftheglobalpopulation.HSV-1
exerts antiapoptotic properties against numerous stimuli. But
some variants including d120 mutant induce apoptosis and
under these conditions, infected cell protein no. 22 (ICP22 or
Mr37,500 protein) leads to an additional product (Mr35,000)
that can result in vitro from ICP22 cleavage by caspase 3.
49
Neither the identity of the caspase site nor the
biological relevance of ICP22 cleavage has been further
investigated yet.
Viruses Face Up to Apoptosis: Die Harder. There are
clear evidences concerning the relevance of viral protein
caspase cleavages in the physiology of viruses (Figure 1).
Coherently, such a modiﬁcation is used to directly ﬁght apop-
tosis and AcMNPV as well as WSSV express proteins acting
as strong and broad inhibitor caspase substrates. For other
viruses, caspase cleavage probably allows the removal of
speciﬁc regions that reveals or eliminates functional domains
or signals. In some cases, this leads to full viral ampliﬁcation
(AMDV NS1, HPV E1), with the striking example of AMDV
NS1 protein that needs to be cleaved by caspases to
translocate to the nucleus and eventually exert its functions.
On the contrary, caspase cleavage can result in the attenua-
tion of the virus by generating new viral products acting as
dominant negatives of NS proteins (H-1PV NS1, KSHV
ORF57) or unﬁt for virus packaging when structural proteins
are concerned (AMDV VP and possibly FCV capsid protein).
Interestingly, such attenuation at a cellular level might hold
importance regarding the possibility for viruses to establish
permissive and/or persistent infection at a higher scale
(i.e. multicellular organisms). The functional consequences
of some viral protein caspase cleavages still remain debated
or elusive because of the difﬁculty of investigating hazardous
entities (inﬂuenza, HCV), the multitude of strains and
genotypes (inﬂuenza, HCV, adenovirus) or the lack of appro-
priate tools such as cellular or animal models allowing
to recapitulate the viral life cycle (TGEV, MCV). When
caspase cleavages of viral proteins work in too mysterious
ways, it is sometimes concluded that they constitute a
mechanism of degradation resulting from the host ﬁghting
back the infection. However, the caspase-related products
detected are mostly stable, suggesting they could be
somehow involved in the viral life cycle as mentioned right
above. Besides, knowing how high the mutation rates of
viruses can be,
50 or that some viral oncoproteins (like v-Rel)
adapted to resist caspase cleavage through evolution unlike
their cellular counterparts,
51 keeping caspase cleavage sites
seems very unlikely if viruses do not somehow proﬁt from
them. As caspase cleavage of viral proteins occurs in all
sorts of proteins (structural or non-structural) and in all sorts
of viruses (DNA as well as RNA), this suggests that it
constitutes a strong strategy to handle apoptosis. By
managing to use the molecular effectors of apoptosis to
protect themselves from eradication without any additional
genetic information required, viruses prove once again how
fascinating their adaptability can be.
Virus
Host cell
Infection
Caspase activation
Cleavage of viral proteins
Inhibitor caspase
substrate
Consequences on the virus
Modification
of the protein functions
(localization)
Modification
of the protein functions
(dominant negative) 
INHIBITION
OF APOPTOSIS
VIRAL
AMPLIFICATION
VIRAL ATTENUATION
Permissive/persistent
balance
Figure 1 Functional consequences of caspase cleavages of VPs. This ﬁgure
summarizes the conclusions we made about the biological relevance of caspase
cleavages of VPs. A virus infecting a host cell is represented, leading to caspase
activation and cleavage of one or several VPs. The consequences of such caspase
cleavages on the viral life cycle are indicated, as well as the possible links between
them
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